Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuous high-titer HIV-1 vector production.

Yasuhiro Ikeda1, Yasuhiro Takeuchi, Francisco Martin

  • 1Department of Immunology and Molecular Pathology, Windeyer Institute, University College London, 46 Cleveland St., London W1T 4JF, UK.

Nature Biotechnology
|April 8, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Analysis of HIV-2 Proviral DNA Reveals Archived Protease Inhibitor Resistance and Reservoir Evolution over Eight Years.

International journal of molecular sciences·2026
Same author

The Cytosolic Zinc Finger Domain Structure of the CCHFV Glycoprotein n Is Maintained in Its Membrane-Bound Form.

Journal of the American Chemical Society·2026
Same author

Observations on an Open-Label Phase 1/2 Dopamine Gene Therapy Trial (OXB-102/Axo-Lenti-PD) in People with Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Editorial: Community Series in Engineered Immune Cells in Cancer Immunotherapy (EICCI), volume II.

Frontiers in immunology·2026
Same author

Fully printable Sb<sub>2</sub>S<sub>3</sub>-based mesoscopic triple-stack solar cells: the influence of infiltration chemistry.

Dalton transactions (Cambridge, England : 2003)·2026
Same author

The Crimean-Congo haemorrhagic fever virus hijacks the liver lipid metabolic pathway for virion production.

Emerging microbes & infections·2026
Same journal

Author Correction: Improved RNA base editing with guide RNAs mimicking highly edited endogenous ADAR substrates.

Nature biotechnology·2026
Same journal

Unlocking the chemical potential of filamentous fungi using prime editing.

Nature biotechnology·2026
Same journal

A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells.

Nature biotechnology·2026
Same journal

Prime editing for precise genome engineering and modulation of fungal metabolism.

Nature biotechnology·2026
Same journal

Retargeted serine integrases for one-step, precise integration of large DNA sequences in human cells.

Nature biotechnology·2026
Same journal

A retargeted recombinase for precise insertion of large DNA.

Nature biotechnology·2026
See all related articles

Stable packaging cells for human immunodeficiency virus type 1 (HIV-1) vector production were developed. This method allows continuous, high-level production of HIV-1 Gag-Pol, overcoming previous limitations in generating large vector batches.

Area of Science:

  • Molecular Biology
  • Virology
  • Biotechnology

Background:

  • Current human immunodeficiency virus type 1 (HIV-1)-based vector production relies on transient transfection or inducible packaging cell lines.
  • Stable HIV-1 packaging cell lines have been challenging to create due to the cytotoxicity of HIV-1 protease, leading to low p24 antigen secretion.

Purpose of the Study:

  • To develop a stable HIV-1 packaging cell line for continuous, high-level vector production.
  • To overcome the limitations of existing methods for generating large batches of HIV-1 vectors.

Main Methods:

  • Utilized a murine leukemia virus (MLV) vector to express HIV-1 Gag-Pol.
  • Constructed stable packaging cells using codon-optimized HIV-1 Gag-Pol and gammaretroviral envelope proteins.

Related Experiment Videos

Main Results:

  • Achieved constitutive, long-term, high-level expression of HIV-1 Gag (up to 850 ng/ml p24).
  • Generated producer cells capable of making up to 10(7) 293T infectious units/ml for over three months.

Conclusions:

  • Stable packaging cells expressing HIV-1 Gag-Pol via an MLV vector enable efficient and reproducible HIV-1 vector production.
  • This approach offers a significant advancement for generating large quantities of HIV-1 vectors for research and therapeutic applications.